Of particular interest, recent evidence indicates that OSA-related sleep disturbances elevate plasma levels of fibroblast growth factor 23 (FGF-23), which is an independent risk factor for CKD progression (60, 61). The gene discussed is FGF23; the disease is obstructive sleep apnea syndrome.